Skip Navigation

Link to  the National Institutes of Health  
The Science of Drug Abuse and Addiction from the National Institute on Drug Abuse Archives of the National Institute on Drug Abuse web site
Go to the Home page
   
NIDA Home >Drugs of Abuse/Related Topics > HIV/AIDS and Drug Abuse > AIDS Research Program > Presentations and Meetings > Intersection of Technology, HAART Adherence, and Drug Abuse Treatment

AIDS Research Program (ARP)

Intersection of Technology, HAART Adherence, and Drug Abuse Treatment

Washington, DC
March 4-5, 2010

The NIDA AIDS Research Program convened a 2-day meeting in Washington, DC. The purpose of the meeting was to encourage multidisciplinary collaboration between social scientists, medical researchers (doctors and nurses), and technology experts to develop and refine mobile technological instrumentation, e-health technology, and software as interventions to foster adherence to HIV treatment regimens and access to care among substance-abusing populations.

Intersection of Tech and HIV Adherence Meeting Summary
Shoshana Y. Kahana, Ph.D.
Program Official
Behavioral and Integrative Treatment Branch
Division of Clinical Neuroscience and Behavioral Research
National Institute on Drug Abuse
Bethesda
MD 20892-9593

Slide Presentations

Highly Active Antiretroviral Therapy and Survival in HIV-Infected Injection Drug Users: Implications for the Critical Role of Adherence
Robert S. Hogg, Ph.D.
Simon Fraser University/BC Centre for Excellence in HIV/AIDS
Vancouver, British Columbia, Canada

Interventions Targeting Medication Adherence and Drug Use for HIV+ Men: Perspectives from an Academic/Outpatient Clinic
Jeffrey T. Parsons, Ph.D.
Co-Director, Center for HIV/AIDS Educational Studies and Training
Hunter College
New York, NY

Interventions Targeting Medication Adherence and Drug Use for HIV+ Criminal Justice Populations
Frederick L. Altice, M.D., and Sandra Springer, M.D.
School of Medicine, Yale University
New Haven, CT

Considerations for Continued Development of Behavioral Interventions Targeting HIV Treatment Adherence
Gregory M. Lucas, M.D., Ph.D.
Division of Infectious Diseases
Johns Hopkins University School of Medicine
Baltimore, MD

Self-Monitoring Applications and Implications for Interventions Targeting Drug Abuse and HIV Treatment Adherence
Mary Jane Rotheram-Borus, Ph.D.
Center for HIV Identification, Prevention, and Treatment Services
University of California at Los Angeles
Los Angeles, CA

Real-Time Electronic Diary Reports of Cue Exposure, Mood, and Drug Use
Kenzie L. Preston, Ph.D.
Intramural Research Program
National Institute on Drug Abuse
Baltimore, MD

Novel Approaches to Monitoring Adherence to HIV Therapy
Jessica E. Haberer, M.D.
Massachusetts General Hospital
Boston, MA

Impact of Frontline SMS, Mobile Phones, and Text Messaging on Health Care Delivery in Rural Malawi
Josh Nesbit
FrontlineSMS:Medic \+/
Washington, DC

The Development of a Web-Based Program to Improve Adherence to HIV/AIDS Medications among Drug Abusers in a Community Clinic
Royer F. Cook, Ph.D.
ISA Associates, Inc.
Arlington, VA

CFAR Network of Integrated Clinical Systems (CNICS): The Use of Real-Time Patient-Centered Clinical Metrics for Substance Abuse and HIV Care
Stephen L. Boswell, M.D.
Fenway Health/Harvard Medical School
Boston, MA

Collaboration with Developers: A Two-Way Learning Experience
Vesta Brue
Inventor and Lead Developer, MedSignals LLC
San Antonio, TX

Creating a Shared, Open, and Scalable Platform for Intervention Innovation
Deborah Estrin, Ph.D.
Director, Center for Embedded Networked Sensing
University of California Los Angeles
Los Angeles, CA

Future Considerations and Lessons Learned from Internet-Based Interventions for HIV/STI Prevention
Lisa A. Marsch, Ph.D.
National Development and Research Institute
New York, NY

Substance Use, ART Adherence, and the Development of Class-Specific Antiretroviral Resistance: Implications for Future Interventions
Edward M. Gardner, M.D.
University of Colorado at Denver
Denver Public Health
Denver, CO

Small Business Innovation Research (SBIR) and Technology Transfer (STTR) Programs
Cathrine A. Sasek, Ph.D.
Office of Science Policy and Communications
National Institute on Drug Abuse
Bethesda, MD

Fostering Public Partner Partnerships
Shawnmarie Mayrand-Chung, Ph.D.
Public-Private Partnership Program, Office of Science Policy
National Institutes of Health
Bethesda, MD

About NIDA Contents


Get Adobe Reader



Archive Home | Accessibility | Privacy | FOIA (NIH) | Current NIDA Home Page
National Institutes of Health logo_Department of Health and Human Services Logo The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH) , a component of the U.S. Department of Health and Human Services. Questions? See our Contact Information. . The U.S. government's official web portal